Cargando…
Soluble activin type IIB receptor improves fracture healing in a closed tibial fracture mouse model
Fractures still present a significant burden to patients due to pain and periods of unproductivity. Numerous growth factors have been identified to regulate bone remodeling. However, to date, only the bone morphogenetic proteins (BMPs) are used to enhance fracture healing in clinical settings. Activ...
Autores principales: | Puolakkainen, Tero, Rummukainen, Petri, Lehto, Jemina, Ritvos, Olli, Hiltunen, Ari, Säämänen, Anna-Marja, Kiviranta, Riku |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5509431/ https://www.ncbi.nlm.nih.gov/pubmed/28704409 http://dx.doi.org/10.1371/journal.pone.0180593 |
Ejemplares similares
-
Treatment with Soluble Activin Type IIB Receptor Ameliorates Ovariectomy-Induced Bone Loss and Fat Gain in Mice
por: Puolakkainen, Tero, et al.
Publicado: (2022) -
Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy
por: Puolakkainen, Tero, et al.
Publicado: (2017) -
Mesenchymal Cell‐Derived Juxtacrine Wnt1 Signaling Regulates Osteoblast Activity and Osteoclast Differentiation
por: Wang, Fan, et al.
Publicado: (2019) -
Multiple targets identified with genome wide profiling of small RNA and mRNA expression are linked to fracture healing in mice
por: Bourgery, Matthieu, et al.
Publicado: (2021) -
Impaired osteoclast homeostasis in the cystatin B-deficient mouse model of progressive myoclonus epilepsy
por: Manninen, Otto, et al.
Publicado: (2015)